India
· Delayed Price · Currency is INR Shukra Pharmaceuticals Statistics
Total Valuation
BOM:524632 has a market cap or net worth of INR 6.53 billion. The enterprise value is 6.45 billion.
| Market Cap | 6.53B |
| Enterprise Value | 6.45B |
Important Dates
The last earnings date was Monday, May 26, 2025.
| Earnings Date | May 26, 2025 |
| Ex-Dividend Date | Sep 23, 2024 |
Share Statistics
BOM:524632 has 437.88 million shares outstanding. The number of shares has decreased by -0.61% in one year.
| Current Share Class | 437.88M |
| Shares Outstanding | 437.88M |
| Shares Change (YoY) | -0.61% |
| Shares Change (QoQ) | +2.13% |
| Owned by Insiders (%) | 43.45% |
| Owned by Institutions (%) | n/a |
| Float | 38.60M |
Valuation Ratios
The trailing PE ratio is 67.77.
| PE Ratio | 67.77 |
| Forward PE | n/a |
| PS Ratio | 17.74 |
| PB Ratio | 10.39 |
| P/TBV Ratio | 10.39 |
| P/FCF Ratio | 126.15 |
| P/OCF Ratio | 82.45 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 38.08, with an EV/FCF ratio of 124.62.
| EV / Earnings | 67.36 |
| EV / Sales | 17.53 |
| EV / EBITDA | 38.08 |
| EV / EBIT | 46.29 |
| EV / FCF | 124.62 |
Financial Position
The company has a current ratio of 3.79, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.79 |
| Quick Ratio | 1.21 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.25 |
| Debt / FCF | 0.81 |
| Interest Coverage | 23.42 |
Financial Efficiency
Return on equity (ROE) is 15.90% and return on invested capital (ROIC) is 13.63%.
| Return on Equity (ROE) | 15.90% |
| Return on Assets (ROA) | 10.58% |
| Return on Invested Capital (ROIC) | 13.63% |
| Return on Capital Employed (ROCE) | 20.05% |
| Revenue Per Employee | 2.02M |
| Profits Per Employee | 526,104 |
| Employee Count | 182 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 1.32 |
Taxes
In the past 12 months, BOM:524632 has paid 37.61 million in taxes.
| Income Tax | 37.61M |
| Effective Tax Rate | 28.20% |
Stock Price Statistics
The stock price has increased by +48.28% in the last 52 weeks. The beta is 0.28, so BOM:524632's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | +48.28% |
| 50-Day Moving Average | 15.86 |
| 200-Day Moving Average | 13.74 |
| Relative Strength Index (RSI) | 55.78 |
| Average Volume (20 Days) | 139,287 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:524632 had revenue of INR 367.94 million and earned 95.75 million in profits. Earnings per share was 0.22.
| Revenue | 367.94M |
| Gross Profit | 286.82M |
| Operating Income | 139.32M |
| Pretax Income | 133.37M |
| Net Income | 95.75M |
| EBITDA | 169.37M |
| EBIT | 139.32M |
| Earnings Per Share (EPS) | 0.22 |
Balance Sheet
The company has 121.18 million in cash and 41.77 million in debt, giving a net cash position of 79.41 million or 0.18 per share.
| Cash & Cash Equivalents | 121.18M |
| Total Debt | 41.77M |
| Net Cash | 79.41M |
| Net Cash Per Share | 0.18 |
| Equity (Book Value) | 628.36M |
| Book Value Per Share | 1.40 |
| Working Capital | 481.44M |
Cash Flow
In the last 12 months, operating cash flow was 79.18 million and capital expenditures -27.43 million, giving a free cash flow of 51.75 million.
| Operating Cash Flow | 79.18M |
| Capital Expenditures | -27.43M |
| Free Cash Flow | 51.75M |
| FCF Per Share | 0.12 |
Margins
Gross margin is 77.95%, with operating and profit margins of 37.86% and 26.02%.
| Gross Margin | 77.95% |
| Operating Margin | 37.86% |
| Pretax Margin | 36.25% |
| Profit Margin | 26.02% |
| EBITDA Margin | 46.03% |
| EBIT Margin | 37.86% |
| FCF Margin | 14.07% |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.67%.
| Dividend Per Share | 0.10 |
| Dividend Yield | 0.67% |
| Dividend Growth (YoY) | 700.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 45.73% |
| Buyback Yield | 0.61% |
| Shareholder Yield | 1.29% |
| Earnings Yield | 1.47% |
| FCF Yield | 0.79% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 21, 2025. It was a forward split with a ratio of 10.
| Last Split Date | Mar 21, 2025 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |